收费全文 | 1683694篇 |
免费 | 136619篇 |
国内免费 | 3031篇 |
耳鼻咽喉 | 22700篇 |
儿科学 | 54930篇 |
妇产科学 | 47399篇 |
基础医学 | 238057篇 |
口腔科学 | 49313篇 |
临床医学 | 149020篇 |
内科学 | 332592篇 |
皮肤病学 | 35385篇 |
神经病学 | 137918篇 |
特种医学 | 68150篇 |
外国民族医学 | 475篇 |
外科学 | 257375篇 |
综合类 | 40416篇 |
现状与发展 | 3篇 |
一般理论 | 726篇 |
预防医学 | 128501篇 |
眼科学 | 38029篇 |
药学 | 126173篇 |
3篇 | |
中国医学 | 3088篇 |
肿瘤学 | 93091篇 |
2018年 | 17558篇 |
2016年 | 15043篇 |
2015年 | 17412篇 |
2014年 | 23970篇 |
2013年 | 35668篇 |
2012年 | 48888篇 |
2011年 | 51278篇 |
2010年 | 29990篇 |
2009年 | 28501篇 |
2008年 | 48383篇 |
2007年 | 50387篇 |
2006年 | 51054篇 |
2005年 | 49638篇 |
2004年 | 48508篇 |
2003年 | 46338篇 |
2002年 | 44907篇 |
2001年 | 76202篇 |
2000年 | 78723篇 |
1999年 | 66985篇 |
1998年 | 18509篇 |
1997年 | 16930篇 |
1996年 | 16804篇 |
1995年 | 16511篇 |
1994年 | 15456篇 |
1993年 | 14603篇 |
1992年 | 55726篇 |
1991年 | 54034篇 |
1990年 | 52805篇 |
1989年 | 51052篇 |
1988年 | 47454篇 |
1987年 | 46778篇 |
1986年 | 44516篇 |
1985年 | 43079篇 |
1984年 | 32319篇 |
1983年 | 27828篇 |
1982年 | 16442篇 |
1981年 | 14720篇 |
1980年 | 13788篇 |
1979年 | 30581篇 |
1978年 | 21229篇 |
1977年 | 17923篇 |
1976年 | 16798篇 |
1975年 | 17681篇 |
1974年 | 21597篇 |
1973年 | 20763篇 |
1972年 | 18934篇 |
1971年 | 17849篇 |
1970年 | 16350篇 |
1969年 | 15312篇 |
1968年 | 13995篇 |
In order to offer early and accessible treatment for adolescents with depression, brief and effective treatments in adolescents’ everyday surroundings are needed. This randomized controlled trial studied the preliminary effectiveness, feasibility, and acceptability of interpersonal counseling (IPC) and brief psychosocial support (BPS) in school health and welfare services. The study was conducted in the 28 lower secondary schools of a large city in Southern Finland, randomized to provide either IPC or BPS. Help-seeking 12–16-year-old adolescents with mild-to-moderate depression, with and without comorbid anxiety, were included in the study. Fifty-five adolescents received either 6 weekly sessions of IPC or BPS and two follow-up sessions. Outcome measures included self- and clinician-rated measures of depression, global functioning, and psychological distress/well-being. To assess feasibility and acceptability of the treatments, adolescents’ and counselors’ treatment compliance and satisfaction with treatment were assessed. Both treatments were effective in reducing depressive disorders and improving adolescents’ overall functioning and well-being. At post-treatment, in both groups, over 50% of adolescents achieved recovery based on self-report and over 70% based on observer report. Effect sizes for change were medium or large in both groups at post-treatment and increased at 6-month follow-up. A trend indicating greater baseline symptom severity among adolescents treated in the IPC-providing schools was observed. Adolescents and counselors in both groups were satisfied with the treatment, and 89% of the adolescents completed the treatments and follow-ups. This trial suggests that both IPC and BPS are feasible, acceptable, and effective treatments for mild-to-moderate depression in the school setting. In addition, IPC seems effective even if comorbid anxiety exists. Our study shows that brief, structured interventions, such as IPC and BPS, are beneficial in treating mild-to-moderate depression in school settings and can be administered by professionals working at school.
Trial registrationhttp://www.clinicaltrials.gov. Unique identifier: NCT03001245.
相似文献Background
The efficacy of dexamethasone in extending the duration of local anaesthetic block is uncertain. In a randomised controlled triple blind crossover study in volunteers, we tested the hypothesis that neither i.v. nor perineurally administered dexamethasone prolongs the sensory block achieved with ropivacaine.Methods
Ultrasound-guided ulnar nerve blocks (ropivacaine 0.75% wt/vol, 3 ml, with saline 1 ml with or without dexamethasone 4 mg) were performed on three occasions in 24 male volunteers along with an i.v. injection of saline 1 ml with or without dexamethasone 4 mg. The combinations of saline and dexamethasone were as follows: control group, perineural and i.v. saline; perineural group, perineural dexamethasone and i.v. saline; i.v. group, perineural saline and i.v. dexamethasone. Sensory block was measured using a VAS in response to pinprick testing. The duration of sensory block was the primary outcome and time to onset of sensory block the secondary outcome.Results
All 24 subjects completed the trial. The median [inter-quartile range (IQR)] duration of sensory block was 6.87 (5.85–7.62) h in the control group, 7.37 (5.78–7.93) h in the perineural group and 7.37 (6.10–7.97) h in the i.v. group (P=0.61). There was also no significant difference in block onset time between the three groups.Conclusion
Dexamethasone 4 mg has no clinically relevant effect on the duration of sensory block provided by ropivacaine applied to the ulnar nerve.Clinical trial registration
DRKS, 00014604; EudraCT, 2018-001221-98. 相似文献Methods: This is a retrospective analysis of discharge records from the National Inpatient Sample database for patients receiving allo-HSCT between 1 January 2009 and 31 December 2013. Allo-HSCT discharges with an aGVHD diagnosis were included in the aGVHD group and those without any graft-versus-host disease (GVHD) diagnosis comprised the non-GVHD group. Mortality, LOS and costs were compared between the two groups, as well as within subgroups, including age (<18 vs. ≥18 years) and survival status (alive vs. deceased) at discharge.
Results: Overall, mortality (16.2% vs. 5.3%; p?<?.01), median hospital LOS (42.0 vs. 26.0 days; p?<?.01) and median total costs ($173,144 vs. $98,982; p?<?.01) were significantly increased in patients with aGVHD versus those without GVHD during hospitalizations for allo-HSCT, irrespective of age group. Patients with aGVHD who were <18 years of age had a lower mortality rate but greater hospital LOS and total costs versus patients aged ≥18 years. Patients who died during allo-HSCT hospitalization had longer LOS and incurred greater costs than those who survived in both the aGVHD and non-GVHD groups.
Conclusion: Occurrence of aGVHD during allo-HSCT admissions resulted in a tripling of the mortality rate and a near doubling of hospital LOS and total costs. In addition, death during allo-HSCT hospitalizations was associated with greater healthcare utilization and costs. Effectively mitigating aGVHD may improve survival and substantially reduce hospital LOS and costs for allo-HSCT. 相似文献